Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Research Informatics Product Growth Manager x3 (US or Switzerland) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development May 08, 2024
Renal Medical Lead Seoul South Korea International Innovative Medicines Research & Development Sep 01, 2024
Regulatory Affairs Medical Device Manager (Schaftenau, Austria) Schaftenau Austria Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs Manager New South Wales (NSW) Australia Development Innovative Medicines Research & Development Oct 06, 2024
Regulatory Affairs Manager Kyiv Ukraine Development Innovative Medicines Research & Development May 10, 2024
Regulatory Affairs Manager Beijing (Beijing) China Development Innovative Medicines Research & Development Sep 01, 2024
Regulatory Affairs CMC Senior Manager Schaftenau Austria Development Innovative Medicines Research & Development Sep 02, 2024
Regulatory Affairs CMC Associate Director Schaftenau Austria Development Innovative Medicines Research & Development Sep 30, 2024
RA Specialist Croatia Croatia Development Innovative Medicines Research & Development Oct 18, 2024
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Oct 16, 2024
RA Manager, Procedural Documents London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 10, 2024
RA Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development May 30, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
RA CMC Associate Manager - II Hyderabad (Office) India Development Innovative Medicines Research & Development Jun 19, 2024
Qualification Expert (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Jul 23, 2024
QC Senior Scientist Ivrea Italy International Innovative Medicines Research & Development Oct 14, 2024
Project Team Coordinator (Medical) (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Oct 15, 2024
Product Manager - Research Informatics (Sample Shipping and Compliance) Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Sep 03, 2024
Process Expert (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Jul 24, 2024
Principle Scientist, Molecular Imaging Expert Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 18, 2024
Principal Scientist, Modeling & Simulation RLT Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Principal Scientist II, Emerging Technologies Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 09, 2024
Principal Scientist II, Cell & Gene Therapy Delivery San Diego USA Biomedical Research Pharma Research Research & Development Oct 17, 2024
Principal Scientist I - Oncology Pathology and Biomarkers (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Sep 05, 2024
Principal Scientist 2 - Preclinical Safety Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Jul 22, 2024
Principal Scientist – Covalency & Exploratory Chemical Biology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 15, 2024
Principal Scientist - Pathology Telangana India Biomedical Research Pharma Research Research & Development Sep 03, 2024
Principal Scientist Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Apr 24, 2024
Principal Scientific Writer Hyderabad (Office) India Operations CTS Research & Development Sep 03, 2024
Principal RWE Research Analyst Hyderabad (Office) India Operations CTS Research & Development May 14, 2024
Principal RWE Research Analyst Hyderabad (Office) India Operations CTS Research & Development Jun 06, 2024
Principal Pharmacometrics Scientist London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 03, 2024
Principal Clinical Data Manager Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Sep 26, 2024
Principal Biostatistician Home Worker United Kingdom Development Innovative Medicines Research & Development Sep 17, 2024
Principal Biostatistician Shanghai (Shanghai) China Development Innovative Medicines Research & Development Jun 20, 2024
Principal /Senior Principal Scientist PKS Oncology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development May 20, 2024
Pipeline Medical Manager CRM London (The Westworks) United Kingdom International Innovative Medicines Research & Development Oct 11, 2024
Patient Safety Specialist Amiria Egypt Development Innovative Medicines Research & Development Aug 26, 2024
Patient Safety Specialist İstanbul Kavacık Turkey Development Innovative Medicines Research & Development Jun 10, 2024
Patient Safety Manager Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Sep 04, 2024
Patient Safety Head US East Hanover USA Development Innovative Medicines Research & Development Jun 28, 2024
Patient Advocacy Manager Prague Czech Republic International Innovative Medicines Research & Development Oct 10, 2024
Patient Advocacy & Medical Lead Prague Czech Republic International Innovative Medicines Research & Development Oct 10, 2024
Oncology MSL INSURGENTES Mexico International Innovative Medicines Research & Development Oct 18, 2024
NS Therapeutic Area Biomarker Lead (Associate Director) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 11, 2024
MSL Tumeurs Solides - Nord Est Field Non-Sales (France) France International Innovative Medicines Research & Development Apr 29, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only